Hsiu-Mei Chang

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Systematic Review

Tyrosine Kinase

Advanced Non Small Cell Lung Cancer

Top Venues

Journal of clinical medicine

Prostate cancer and prostatic diseases

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Wen-Han Feng, Yong-Chieh Chang, Yi-Hsiung Lin, Hsiao-Ling Chen, Chun-Yin Chen, Tsung-Han Lin, Tzu-Chieh Lin, Ching-Tang Chang, Hsuan-Fu Kuo, Hsiu-Mei Chang, Chih-Sheng Chu
P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-Analysis. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Wen-Han Feng, Yong-Chieh Chang, Yi-Hsiung Lin, Hsiao-Ling Chen, Hsiu-Mei Chang, Chih-Sheng Chu
Comparative Efficacy and Safety of P2Y12 Inhibitor Monotherapy and Dual Antiplatelet Therapy in Patients with and without Diabetes Mellitus Undergoing Percutaneous Coronary Intervention. International journal of molecular sciences 23 (9) (2022)
Tai-Huang Lee, Hsiao-Ling Chen, Hsiu-Mei Chang, Chiou-Mei Wu, Kuan-Li Wu, Chia-Yu Kuo, Po-Ju Wei, Chin-Ling Chen, Hui-Lin Liu, Yu-Kang Tu, Chih-Jen Yang, Inn-Wen Chong
Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis. Journal of clinical medicine 11 (12) (2022)
Cheng-Hao Chuang, Hsiao-Ling Chen, Hsiu-Mei Chang, Yu-Chen Tsai, Kuan-Li Wu, I-Hua Chen, Kung-Chao Chen, Jui-Ying Lee, Yong-Chieh Chang, Chin-Ling Chen, Yu-Kang Tu, Chih-Jen Yang, Chih-Jen Yang, Inn-Wen Chong
Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer. Cancers 13 (8) (2021)
Kuan-Li Wu, Hsiao-Ling Chen, Ying-Ming Tsai, Tai-Huang Lee, Hsiu-Mei Chang, Yu-Chen Tsai, Cheng-Hao Chuang, Yong-Chieh Chang, Chin-Ling Chen, Chih-Jen Yang, Yu-Kang Tu, Inn-Wen Chong
First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-Analysis. Journal of clinical medicine 10 (19) (2021)
Yu-Chen Tsai, Hsiao-Ling Chen, Tai-Huang Lee, Hsiu-Mei Chang, Kuan-Li Wu, Cheng-Hao Chuang, Yong-Chieh Chang, Chin-Ling Chen, Yu-Kang Tu, Chih-Jen Yang, Inn-Wen Chong
Salvage Therapy for Relapsed Malignant Pleural Mesothelioma: A Systematic Review and Network Meta-Analysis. Cancers 14 (1) (2021)
Hsiao-Ling Chen, Chin-Ling Chen, Hsiu-Mei Chang, Tai-Huang Lee, Kuan-Li Wu, Yu-Chen Tsai, Mei-Hsuan Lee, Chih-Jen Yang, Jen-Yu Hung, Inn-Wen Chong
Systematic Review and Network Meta-Analysis of Immune Checkpoint Inhibitors in Combination with Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Carcinoma. Cancers 12 (12) (2020)
Hsiang Ying Lee, Hsiao-Ling Chen, Jeremy Yuen Chun Teoh, Tun-Chieh Chen, Shao-Yuan Hao, Hsin-Yi Tsai, Wei-Hsuan Huang, Yung-Shun Juan, Hao-Min Cheng, Hsiu-Mei Chang
Abiraterone and enzalutamide had different adverse effects on the cardiovascular system: a systematic review with pairwise and network meta-analyses. Prostate cancer and prostatic diseases 24 (1) (2020)